Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | HFWA | UVSP |
|---|---|---|
| Price | $27.24 | $40.89 |
| Change today | ▼ 1.63% | ▼ 1.16% |
| Market cap | $1.11B | $1.13B |
| Return, 3 months | -5.9% | -6.2% |
| Return, year to date | +18.2% | +27.1% |
| Return, 1 year | +18.4% | +40.5% |
| P/E (TTM) | 13.0 | 11.8 |
| P/B | 1.0 | 1.2 |
| P/E percentile vs own 5y | 48th | 86th |
| Dividend yield | 3.52% | 2.18% |
| Revenue growth (YoY, latest qtr) | +48.9% | +4.1% |
| Net profit growth (YoY) | +43.6% | +14.9% |
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | 26.5% | 29.0% |
| Return on equity | 7.8% | 10.5% |
| Analyst target vs. price | +20.2% | +14.9% |
| Analyst buy share | 50% | 0% |
| RSI (14) | 35 | 38 |
| 30-day volatility | 15.5% | 12.2% |
| Max drawdown, 1 year | -13.0% | -9.1% |
| Trend read | Leaning bearish | Leaning bearish |
| Analyst consensus | Buy | Hold |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
